Skip to content
Home

Stanley Cohen — Nobel-winning biochemist and genetic engineering pioneer

American biochemist (1922–2020), Nobel Prize laureate for discovery of growth factors and an early developer of recombinant DNA techniques that shaped cancer research and biotechnology.

Overview: Stanley Cohen was an American biochemist whose laboratory discoveries reshaped understanding of how cells grow, differentiate and respond to signals. He shared the 1986 Nobel Prize in Physiology or Medicine for work that identified protein growth factors and clarified the molecular events that control cell proliferation. His research bridged basic biology and medical application and helped open new routes for cancer therapy and biotechnology. For a concise profile, see biochemist profile.

Image gallery

3 Images

Major scientific contributions

Cohen is best known for isolating and characterizing epidermal growth factor (EGF) and for demonstrating the existence of specific cellular receptors that bind growth factors. These findings provided a molecular explanation for how external signals direct cell growth and division. The discovery illuminated mechanisms underlying normal development and disease, particularly cancer, where signaling pathways can become dysregulated. Summaries of his scientific work are available at research summaries.

Genetic engineering and early recombinant DNA work

In the early 1970s Cohen collaborated indirectly with contemporaries who developed plasmid-based cloning techniques. His laboratory experiments, together with related work by others, were among the first to demonstrate that DNA molecules can be isolated, manipulated and transferred across organisms. This body of work, which is part of the history of genetic engineering, helped establish methods that later enabled gene cloning, molecular diagnostics and the biotech industry. The partnership and scientific link with colleague Herbert Boyer is often cited in accounts of those formative years.

Impact on medicine and biotechnology

The conceptual advance of growth factors and receptors informed drug discovery: pharmaceutical approaches that target growth factor receptors (for example, EGFR inhibitors) trace their rationale to Cohen's findings. His work contributed to a shift from descriptive pathology toward molecularly targeted therapies and influenced how researchers design anti-cancer agents and regenerative medicine strategies. Broader discussions of cancer biology reference these developments at cancer research.

Notable facts and legacy

  • Recipient of the 1986 Nobel Prize in Physiology or Medicine for discoveries concerning growth factors.
  • Recognized as a key figure in the early era of recombinant DNA and biotechnology development.
  • His discoveries connected basic biochemical research to practical clinical applications, changing approaches to drug design and molecular medicine.

Cohen's career exemplifies how molecular discoveries can lead to both conceptual advances and tangible medical tools. For further context on his life and influence, consult general biographical sources and scientific retrospectives linked at biochemist profile and research summaries.

Questions and answers

Q: Who was Stanley Cohen?

A: Stanley Cohen was an American biochemist of Jewish descent.

Q: What did Stanley Cohen win in 1986?

A: Stanley Cohen won the Nobel Prize in Physiology or Medicine in 1986.

Q: What did Stanley Cohen's research help people understand?

A: Stanley Cohen's research helped people understand how cancer starts and how to design anti-cancer drugs.

Q: What did Stanley Cohen do with Herbert Boyer?

A: Stanley Cohen, with Herbert Boyer, was one of the first to do any kind of genetic engineering.

Q: When was Stanley Cohen born?

A: Stanley Cohen was born on November 17, 1922.

Q: When did Stanley Cohen pass away?

A: Stanley Cohen passed away on February 5, 2020.

Q: What was the area of expertise of Stanley Cohen?

A: Stanley Cohen was an expert in biochemistry and genetic engineering.

Author

AlegsaOnline.com Stanley Cohen — Nobel-winning biochemist and genetic engineering pioneer

URL: https://en.alegsaonline.com/art/131128

Share